DOW JONES27,595.64-365.16 -1.31%
S&P 5003,181.66-44.23 -1.37%
NASDAQ9,122.19-99.09 -1.07%

Oppenheimer Initiates Coverage On Soleno Therapeutics with Outperform Rating, Announces $10 Price Target

Oppenheimer analyst Leland Gershell initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Outperform rating and a $10 price target.

Benzinga · 12/23/2019 12:09

Oppenheimer analyst Leland Gershell initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Outperform rating and a $10 price target.